Immunotherapy of cancer with L-phenylalanine mustard as a hapten.
D000818:Animals; D002279:Carcinoma 256, Walker / Q000276:immunology / Q000628:therapy*; D002352:Carrier Proteins; D006241:Haptens / Q000627:therapeutic use*; D006854:Hydrocortisone / Q000494:pharmacology; D007106:Immune Sera / Q000008:administration & dosage; D007116:Immunization, Passive; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007267:Injections; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008297:Male; D008558:Melphalan / Q000008:administration & dosage / Q000627:therapeutic use*; D051381:Rats; D011919:Rats, Inbred Strains
D002352:Carrier Proteins; D006241:Haptens; D007106:Immune Sera; D007166:Immunosuppressive Agents; D008558:Melphalan; D006854:Hydrocortisone